No Data
No Data
Why Iovance Biotherapeutics (IOVA) Is Among the Best Low Priced Biotech Stocks to Buy Now
Need To Know: Analysts Just Made A Substantial Cut To Their Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Estimates
Truist Financial Maintains Iovance Biotherapeutics(IOVA.US) With Hold Rating, Maintains Target Price $5
Iovance Biotherapeutics Is Maintained at Outperform by Mizuho
Iovance Biotherapeutics Price Target Cut to $10.00/Share From $30.00 by Mizuho
Barclays Maintains Overweight on Iovance Biotherapeutics, Lowers Price Target to $4